These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5850269)

  • 1. Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine.
    Resnick O; Krus DM; Raskin M
    Life Sci; 1965 Jul; 4(14):1433-7. PubMed ID: 5850269
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of particulate norepinephrine by d-LSD-25 and reserpine.
    Sankar DV; Domjan M
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):205-14. PubMed ID: 4686104
    [No Abstract]   [Full Text] [Related]  

  • 3. Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
    Halaris AE; Freedman DX
    J Pharmacol Exp Ther; 1977 Dec; 203(3):575-86. PubMed ID: 925959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of LSD and reserpine on the central nervous system of the cat; the antagonism between LSD and chlorpromazine or reserpine.
    TAKAGI H; YAMAMOTO S; TAKAORI S; OGIU K
    Jpn J Pharmacol; 1958 Mar; 7(2):119-34. PubMed ID: 13563000
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of reserpine-serotonin preparation on the brain and their suppression by reserpine antagonists: Iproniazid (marsilid) and LSD].
    MONNIER M; TISSOT R
    Schweiz Arch Neurol Psychiatr; 1958; 82(1-2):218-28. PubMed ID: 13615265
    [No Abstract]   [Full Text] [Related]  

  • 7. LSD-25 ACTION IN NORMAL SUBJECTS TREATED WITH A MONOAMINE OXIDASE INHIBITOR.
    RESNICK O; KRUS DM; RASKIN M
    Life Sci (1962); 1964 Nov; 3():1207-14. PubMed ID: 14231769
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral reaction of rats pretreated with reserpine to LSD-25.
    Votava Z; Glisson SN; Himwich HE
    Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of psychotomimetic compounds on human pseudocholinesterase.
    FRIED GH; ANTOPOL W
    J Appl Physiol; 1957 Jul; 11(1):25-8. PubMed ID: 13462913
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of LSD on synthesis and release of 5-HT in rat brain slices.
    Hamon M; Bourgoin S; Jagger J; Glowinski J
    Brain Res; 1974 Apr; 69(2):265-80. PubMed ID: 4823095
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction.
    ISBELL H; LOGAN CR
    AMA Arch Neurol Psychiatry; 1957 Apr; 77(4):350-8. PubMed ID: 13410191
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexplained inhibitory action of D-lysergic acid diethylamide (LSD) on postganglionic motor transmission in the guinea-pig vas deferens.
    Ambache N; Dunk LP; Miall P; Zar MA
    Br J Pharmacol; 1971 Aug; 42(4):659P-660P. PubMed ID: 4329987
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.
    Dixon AK
    Experientia; 1968 Jul; 24(7):743-7. PubMed ID: 4387561
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of delta9-tetrahydrocannabinol with reserpine, phenobarbital, and LSD-25 on plasma and adrenal corticosterone.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1977 Dec; 42(3):505-12. PubMed ID: 601793
    [No Abstract]   [Full Text] [Related]  

  • 18. Reserpine suppression of dorsal raphe neuronal firing: mediation by adrenergic system.
    Baraban JM; Wang RY; Aghajanian G
    Eur J Pharmacol; 1978 Nov; 52(1):27-36. PubMed ID: 214312
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of lysergic acid diethylamide on larval growth.
    SANKAR DV; KOPELMAN A; SCHILDER P; GOLD E
    Nature; 1960 Jul; 187():153-4. PubMed ID: 14441518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.